Bandingkan Harga & Kinerja Megalestari Epack Sentosaraya Tbk. (EPAC) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Megalestari Epack Sentosaraya Tbk. dan Organon Pharma Indonesia Tbk.: Megalestari Epack Sentosaraya Tbk. diperdagangkan di Rp55 (kapitalisasi pasar 181,69 M, volume 24 jam 23,97 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Megalestari Epack Sentosaraya Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| EPAC | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 181,69 M | 104,4 M |
Volume | 23,97 jt | — |
Lot | 239,69 rb | — |
Perputaran | 1,29 M | — |
Harga Rata-rata | 53,97 | — |
Nilai Transaksi | 1,29 M | — |
Harga Ekuilibrium Indikatif | 55 | — |
Volume Ekuilibrium Indikatif | 3,42 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Megalestari Epack Sentosaraya Tbk.
PT Megalestari Epack Sentosaraya Tbk ("Company") formerly PT Era Prima Adi Cipta Kreasindo and its subsidiaries (together the "Group") was established based on the Deed No.55, dated June 18, 2013 of Poppie Savitri Martosuhardjo Pharmanto, S.H., notary in Jakarta.
Selengkapnya di halaman EPAC →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
